SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation
Clinical trial NCT04486937 · UNKNOWN
Trial details
- NCT number
- NCT04486937
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-30
- Primary completion
- 2021-12-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.